chlorpropamide has been researched along with Carcinoma, Epidermoid in 1 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MS | 1 |
| Chang, X | 1 |
| LeBron, C | 1 |
| Nagpal, JK | 1 |
| Lee, J | 1 |
| Huang, Y | 1 |
| Yamashita, K | 1 |
| Trink, B | 1 |
| Ratovitski, EA | 1 |
| Sidransky, D | 1 |
1 other study available for chlorpropamide and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.
Topics: Animals; Apoptosis; beta Catenin; Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cell Line, | 2010 |